Oxybuprocaine Hydrochloride/Fluorescein Sodium | Interleukin Related interleukin-related.com

Product Name :
Oxybuprocaine Hydrochloride/Fluorescein Sodium

Search keywords :
Fluorescein (sodium)

drugId :
null

Target Vo:
Sodium channel alpha subunit

Target Vo Short Name :
SCNA

Moa_Name:
Sodium channel alpha subunit modulators

First Approval Country :
United States

First Approval Date Filter:
2020

Origin Company_Name :
Bausch Health Ireland Ltd

Active Company_Name :
Bausch Health Ireland Ltd

Active Indication_Name:
Contrast agents

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Approved

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
MLKL Antibody
NF-κB p105/p50 Antibody
ERCC1 Antibody (YA770): ERCC1 Antibody (YA770) is a non-conjugated and Mouse origined monoclonal antibody about 33 kDa, targeting to ERCC1 (7F6). It can be used for WB assays with tag free, in the background of Human.

Author: Interleukin Related

Related Posts